LIGAND PHARMACEUTICALS INC — Investor Relations & Filings
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-18 | English | |
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46385520 | DEFA14A | 2026-05-18 | English | ||
| 46385526 | 8-K | 2026-05-18 | English | ||
| 46155763 | 10-Q | 2026-05-08 | English | ||
| 42834703 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | ||
| 46155787 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155789 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155782 | 8-K | 2026-04-30 | English | ||
| 46155792 | DEFA14A | 2026-04-27 | English | ||
| 37461463 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-27 | English | ||
| 46155795 | ARS | 2026-04-21 | English | ||
| 46155796 | DEFA14A | 2026-04-21 | English | ||
| 34907767 | DEF 14A - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-21 | English | ||
| 33067636 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067397 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067331 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
Market data
Market data not available
Price history
Peer group · Other financial service activities n.e.c., except insurance and pension funding activities
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Genesis Acquisition Corp.
Capital Pool Company (CPC) identifying assets and intending…
|
REBL.P | CA | Financial and insurance activit… |
|
GENUS PRIME INFRA LIMITED
Engages in securities investments, real estate, and infrast…
|
532425 | IN | Financial and insurance activit… |
|
Get Nice Holdings Limited
Investment holding company operating in diversified financi…
|
64 | HK | Financial and insurance activit… |
|
GFA Co.,Ltd.
A multifaceted company in finance, cyber security, space pr…
|
8783 | JP | Financial and insurance activit… |
|
GF Securities Co., Ltd.
Comprehensive financial services: wealth management, invest…
|
1776 | HK | Financial and insurance activit… |
|
GF SECURITIES CO.,LTD
Provides wealth management, investment banking, institution…
|
000776 | CN | Financial and insurance activit… |
|
GigCapital8 Corp
A SPAC facilitating private-to-public equity transitions fo…
|
GIW | US | Financial and insurance activit… |
|
G.k.Consultants Ltd.
Provides financial advisory, investment management, and cor…
|
531758 | IN | Financial and insurance activit… |
|
Global Capital Markets Ltd.
Provides investment management, capital market operations, …
|
530263 | BS | Financial and insurance activit… |
|
Global Investments Capital Corp.
Capital Pool Company (CPC) identifying assets to complete a…
|
GLIN.P | CA | Financial and insurance activit… |
LIGAND PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31289/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31289 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31289 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31289 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31289}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIGAND PHARMACEUTICALS INC (id: 31289)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.